Tumor Biology

, Volume 37, Issue 12, pp 16065–16075 | Cite as

Upregulated long non-coding RNA BC032469 enhances carcinogenesis and metastasis of esophageal squamous cell carcinoma through regulating hTERT expression

  • Chaojing Lu
  • Lixin Yang
  • Hezhong Chen
  • Zhengxiang Shan
Original Article


Currently, long non-coding RNAs (lncRNAs) have been shown to have critical regulatory roles in various cancers. However, its role in esophageal squamous cell carcinoma (ESCC) remains largely unknown. Here, we focused on lncRNA BC032469, one of the lncRNAs involved in the development of ESCC. The levels of a specific differentially expressed lncRNA (termed lncRNA-BC032469) were measured in 45 paired esophageal squamous cell carcinoma tissue samples by quantitative real-time RT-PCR and then subjected to correlation analysis with clinical parameters and prognosis. The functions of lncRNA-BC032469 were evaluated by silencing and overexpressing the lncRNA in vitro and in vivo. The expression level of BC032469 in esophageal squamous cell carcinoma tissues was higher than that in the corresponding non-cancerous tissues. High BC032469 levels were correlated with lymph node metastasis, TNM stage, and tumor size and lower overall survival. Knockdown of BC032469 in TE13 and Eca109 cells inhibited cell proliferation, migration, and invasion; induced cell cycle arrest in the G0/G1 phase; and promoted apoptosis. Western blot analysis revealed that BC032469 regulated the expression of human telomerase reverse transcriptase (hTERT), which is important for cell proliferation and metastasis. Moreover, the restored expression of hTERT protein in BC032469-knockdown cells attenuated the suppressive effects of BC032469 on ESCC cells. Collectively, these results indicated that lncRNA-BC032469 is an oncogenic lncRNA that promotes tumor progression and leads us to propose that lncRNAs may serve as key regulatory hubs in ESCC development.


Esophageal squamous cell carcinoma LncRNAs lncRNA-BC032469 hTERT Proliferation Invasion Prognosis 


Compliance with ethical standards

Ethics statement

This study was approved by the Ethics Committee of Changhai Hospital, Second Military Medical University, and written informed consent was obtained from each patient. All animal research protocols were approved by the Animal Care and Use Ethics Committee of Second Military Medical University.

Conflicts of interest



  1. 1.
    Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World journal of gastrointestinal oncology. 2014;6(5):112–20. doi: 10.4251/wjgo.v6.i5.112.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12. doi: 10.1016/S0140-6736(12)60643-6.CrossRefPubMedGoogle Scholar
  3. 3.
    Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87(4):1048–54 discussion 54-5. doi: 10.1016/j.athoracsur.2008.12.060.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95(7):1434–43. doi: 10.1002/cncr.10868.CrossRefPubMedGoogle Scholar
  5. 5.
    Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 2007;316(5830):1484–8. doi: 10.1126/science.1138341.CrossRefPubMedGoogle Scholar
  6. 6.
    Dinger ME, Pang KC, Mercer TR, Crowe ML, Grimmond SM, Mattick JSNRED. A database of long noncoding RNA expression. Nucleic Acids Res. 2009;37(Database issue):D122–6. doi: 10.1093/nar/gkn617.CrossRefPubMedGoogle Scholar
  7. 7.
    Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, et al. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008;14(7):723–30. doi: 10.1038/nm1784.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res. 2010;1338:20–35. doi: 10.1016/j.brainres.2010.03.110.CrossRefPubMedGoogle Scholar
  9. 9.
    Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6. doi: 10.1038/nature08975.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008;451(7175):202–6. doi: 10.1038/nature06468.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Deng L, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. Journal of experimental & clinical cancer research : CR. 2015;34:18. doi: 10.1186/s13046-015-0136-7.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Lin L, Gu ZT, Chen WH, Cao KJ. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Diagn Pathol. 2015;10:14. doi: 10.1186/s13000-015-0247-7.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Wang YL, Bai Y, Yao WJ, Guo L, Wang ZM. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival. International journal of clinical and experimental pathology. 2015;8(9):11871–6.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Cui F, Wu D, He X, Wang W, Xi J, Wang M. Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016. doi: 10.1007/s13277-016-4962-9.Google Scholar
  15. 15.
    Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19(11):1438–49. doi: 10.1038/nm.3336.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zhou XU, Lu J, Zhu H. Correlation between the expression of hTERT gene and the clinicopathological characteristics of hepatocellular carcinoma. Oncol Lett. 2016;11(1):111–5. doi: 10.3892/ol.2015.3892.PubMedGoogle Scholar
  17. 17.
    MH L, Tang B, Zeng S, CJ H, Xie R, YY W, et al. Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer. Oncogene. 2015. doi: 10.1038/onc.2015.413.Google Scholar
  18. 18.
    Yang L, Froberg JE, Lee JT. Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci. 2014;39(1):35–43. doi: 10.1016/j.tibs.2013.10.002.CrossRefPubMedGoogle Scholar
  19. 19.
    Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–307. doi: 10.1016/j.cell.2013.02.012.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Zhou S, Wang J, Zhang Z. An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol. 2014;140(12):1989–95. doi: 10.1007/s00432-014-1699-y.CrossRefPubMedGoogle Scholar
  21. 21.
    Yan B, Wang Z. Long noncoding RNA: its physiological and pathological roles. DNA Cell Biol. 2012;31(Suppl 1):S34–41. doi: 10.1089/dna.2011.1544.PubMedGoogle Scholar
  22. 22.
    Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans. 2012;40(4):902–6. doi: 10.1042/BST20120020.CrossRefPubMedGoogle Scholar
  23. 23.
    Amicone L, Citarella F, Cicchini C. Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs. Biomed Res Int. 2015;2015:473942. doi: 10.1155/2015/473942.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lee JT. Epigenetic regulation by long noncoding RNAs. Science. 2012;338(6113):1435–9. doi: 10.1126/science.1231776.CrossRefPubMedGoogle Scholar
  25. 25.
    Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer discovery. 2011;1(5):391–407. doi: 10.1158/2159-8290.CD-11-0209.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Chen X, Kong J, Ma Z, Gao S, Feng X. Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. Am J Cancer Res. 2015;5(9):2808–15.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. International journal of clinical and experimental pathology. 2014;7(11):7938–44.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT. Gene. 2001;269(1–2):1–12.CrossRefPubMedGoogle Scholar
  29. 29.
    Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 1998;18(1):65–8. doi: 10.1038/ng0198-65.CrossRefPubMedGoogle Scholar
  30. 30.
    Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast Jr RC, et al. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis. 2007;28(1):174–82. doi: 10.1093/carcin/bgl115.CrossRefPubMedGoogle Scholar
  31. 31.
    Yu ST, Chen L, Wang HJ, Tang XD, Fang DC, Yang SM. hTERT promotes the invasion of telomerase-negative tumor cells in vitro. Int J Oncol. 2009;35(2):329–36.PubMedGoogle Scholar
  32. 32.
    Kumari A, Srinivasan R, Vasishta RK, Wig JD. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer. Ann Surg Oncol. 2009;16(4):1051–9. doi: 10.1245/s10434-009-0333-8.CrossRefPubMedGoogle Scholar
  33. 33.
    Deblakshmi RK, Deka M, Saikia AK, Sharma BK, Singh N, Das NN, et al. Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma. Asian Pacific journal of cancer prevention : APJCP. 2015;16(7):2923–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Safont MJ, Gil M, Sirera R, Jantus-Lewintre E, Sanmartin E, Gallach S, et al. The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2011;13(6):396–400. doi: 10.1007/s12094-011-0673-2.CrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Chaojing Lu
    • 1
  • Lixin Yang
    • 1
  • Hezhong Chen
    • 1
  • Zhengxiang Shan
    • 1
  1. 1.Department of Thoracic SurgeryChanghai Hospital, Second Military Medical UniversityShanghaiChina

Personalised recommendations